X0306 4 2019-06-14 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001458753 Ross Leonard S C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 false true false false See Remarks Common Stock 2019-06-14 4 M false 8280.00 0.00 A 87732.00 D Common Stock 2019-06-14 4 F false 2394.00 1.53 D 85338.00 D Restricted Stock Units 0.00 2019-06-14 4 M false 8280.00 0.00 D Common Stock 8280.00 16560.00 D Restricted stock units convert into common stock on a one-for-one basis. No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units On June 14, 2018, the reporting person was granted 24,840 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Vice President of Finance and Chief Accounting Officer /s/ John Mercer, Attorney-in-Fact 2019-06-17